Instylla

Developer of hydrogel technology for embolization therapy

placeMassachusetts, United States calendar_todayFounded 2017 groups26 employees language instylla.com

Registered entities

Social engagement

Social engagement: 3.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Delos Capital, Excelestar Ventures, CHV, AMED Ventures.

Investor typeCountShare
Venture capital675%
Private equity113%
Other / undisclosed113%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

3 Jan 2026 · HR Coordinator · Bedford

20 Nov 2025 · Manufacturing Engineering Manager · Bedford

Based on job postings tracked across public sources.

Recent activity

24 Jun 2026
Event
Virtual Liquid & Conformable Embolic Summit
12 Jun 2026
Product launch
Embrace® HES
10 Jun 2026
Event
2026 Global Embolization Symposium & Technologies (GEST) Liquid & Conformable Embolic Summit
Coming soon